398120 — SG HealthCare Co Cashflow Statement
0.000.00%
- KR₩36bn
- KR₩35bn
- KR₩16bn
- 36
- 23
- 19
- 12
Annual cashflow statement for SG HealthCare Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -451 | 1,776 | -3,533 |
Depreciation | |||
Amortisation | |||
Non-Cash Items | 3,857 | 1,745 | 4,007 |
Unusual Items | |||
Equity in Net Earnings/Losses | |||
Other Non-Cash Items | |||
Changes in Working Capital | -5,368 | -3,219 | 268 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Change in Taxes Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -1,666 | 606 | 1,111 |
Capital Expenditures | -366 | -1,311 | -4,047 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 2,536 | 5.61 | 243 |
Sale of Fixed Assets | |||
Sale/Maturity of Investment | |||
Purchase of Investments | |||
Sale of Intangible Assets | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | 2,170 | -1,306 | -3,804 |
Financing Cash Flow Items | — | 33.2 | 11,307 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 793 | -393 | 8,473 |
Foreign Exchange Effects | |||
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 1,077 | -1,108 | 5,844 |